Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 323 results

Search term: MF = 'C_{31}H_{29}N_{3}O_{7}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
2736395

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H29N3O7/c1-20(32-27(35)22-12-6-3-7-13-22)30(37)39-18-25-26(41-29(34-25)24-16-10-5-11-17-24)19-40-31(38)21(2)33-28(36)23-14-8-4-9-15-23/h3-17,20-21H,18-19H2,1-2H3,(H,32,35)(H,33,36)
C31H29N3O7555.577859999999151100
5018505

Double-bond stereo
InChI=1/C31H29N3O7/c1-20-8-11-22(12-9-20)30(35)33-25(31(36)32-17-16-21-10-14-28(39-2)29(18-21)40-3)19-23-13-15-27(41-23)24-6-4-5-7-26(24)34(37)38/h4-15,18-19H,16-17H2,1-3H3,(H,32,36)(H,33,35)/b25-19-
C31H29N3O7555.577914900
17462936

Double-bond stereo
InChI=1/C31H29N3O7/c1-4-19-10-12-22(13-11-19)34-30(37)24(28(35)32-31(34)38)17-23-21(16-25-27(26(23)39-3)41-18-40-25)14-15-33(2)29(36)20-8-6-5-7-9-20/h5-13,16-17H,4,14-15,18H2,1-3H3,(H,32,35,38)/b24-17-
C31H29N3O7555.577912900
17470344

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C31H29N3O7/c1-37-25-11-18(12-26(38-2)30(25)39-3)29-28-20(19-6-4-5-7-21(19)32-28)13-22-31(36)33(15-27(35)34(22)29)14-17-8-9-23-24(10-17)41-16-40-23/h4-12,22,29,32H,13-16H2,1-3H3/t22-,29?/m0/s1
C31H29N3O7555.577912800
1853183

Double-bond stereo
InChI=1/C31H29N3O7/c1-4-38-31(37)28-19(2)29(32-20(28)3)24(35)18-41-27(36)13-11-22-17-34(23-8-6-5-7-9-23)33-30(22)21-10-12-25-26(16-21)40-15-14-39-25/h5-13,16-17,32H,4,14-15,18H2,1-3H3/b13-11+
C31H29N3O7555.5779111000
10918303
InChI=1/C31H29N3O7/c1-40-26(36)19-34-29(37)27(28(32)33(31(34)39)18-22-12-6-3-7-13-22)25(35)20-41-30(38)24-15-9-8-14-23(24)17-16-21-10-4-2-5-11-21/h2-15H,16-20,32H2,1H3
C31H29N3O7555.577910800
10918423
InChI=1/C31H29N3O7/c1-40-27(37)19-34-30(38)28(29(32)33(31(34)39)18-21-11-5-2-6-12-21)25(35)20-41-26(36)17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24H,17-20,32H2,1H3
C31H29N3O7555.577910800
17471506

2 of 4 defined stereocentres - 2/4 defined
InChI=1/C31H29N3O7/c1-3-16-5-11-21-20(13-16)31(30(40)32-21)26-25(22(33-31)14-17-6-12-23(35)24(36)15-17)27(37)34(28(26)38)19-9-7-18(8-10-19)29(39)41-4-2/h5-13,15,22,25-26,33,35-36H,3-4,14H2,1-2H3,(H,32,40)/t22?,25-,26+,31?/m1/s1
C31H29N3O7555.57799800
32512034

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-39-16-19-13-27(35)29(37)30(41-19)22(23-11-17-7-8-18(40-2)12-25(17)33-31(23)38)14-28(36)34-10-9-21-20-5-3-4-6-24(20)32-26(21)15-34/h3-8,11-13,22,32,37H,9-10,14-16H2,1-2H3,(H,33,38)
C31H29N3O7555.57799800
32512285

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-39-16-19-13-27(35)29(37)30(41-19)22(23-12-17-11-18(40-2)7-8-24(17)33-31(23)38)14-28(36)34-10-9-21-20-5-3-4-6-25(20)32-26(21)15-34/h3-8,11-13,22,32,37H,9-10,14-16H2,1-2H3,(H,33,38)
C31H29N3O7555.57799800
35146040

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-17-11-25(35)29(31(38)34(17)8-7-18-16-32-23-6-4-3-5-20(18)23)21(14-28(36)39-2)22-12-19-13-26-27(41-10-9-40-26)15-24(19)33-30(22)37/h3-6,11-13,15-16,21,32,35H,7-10,14H2,1-2H3,(H,33,37)
C31H29N3O7555.57798800
320314

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-39-28-23(14-22-10-7-11-24(15-22)40-19-21-8-3-2-4-9-21)16-33(31(38)32-28)20-41-25(18-35)17-34-29(36)26-12-5-6-13-27(26)30(34)37/h2-13,15-16,25,35H,14,17-20H2,1H3
C31H29N3O7555.57798600
329870

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-23(41-30(35)32-27-20-28(33(36)37)22-29(21-27)34(38)39)12-11-19-40-31(24-13-5-2-6-14-24,25-15-7-3-8-16-25)26-17-9-4-10-18-26/h2-10,13-18,20-23H,11-12,19H2,1H3,(H,32,35)
C31H29N3O7555.57798600
34430666

Double-bond stereo
InChI=1/C28H22N2O6.C3H7NO/c31-25(29-14-19-4-3-11-33-19)15-34-28(32)26-20-5-1-2-6-22(20)30-27-18(8-9-21(26)27)12-17-7-10-23-24(13-17)36-16-35-23;1-4(2)3-5/h1-7,10-13H,8-9,14-16H2,(H,29,31);3H,1-2H3/b18-12-;
C31H29N3O7555.57797900
8500850

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C31H29N3O7/c1-2-26(30(39)33-25(18-28(36)37)27(35)19-41-21-12-4-3-5-13-21)34-17-9-16-24(31(34)40)32-29(38)23-15-8-11-20-10-6-7-14-22(20)23/h3-17,25-26H,2,18-19H2,1H3,(H,32,38)(H,33,39)(H,36,37)/t25-,26?/m0/s1
C31H29N3O7555.57796400
7921854

Double-bond stereo
InChI=1/C31H29N3O7/c1-19-8-7-10-21(14-19)31(37)41-25-13-12-20-9-5-6-11-23(20)24(25)17-33-34-28(35)18-32-30(36)22-15-26(38-2)29(40-4)27(16-22)39-3/h5-17H,18H2,1-4H3,(H,32,36)(H,34,35)/b33-17+
C31H29N3O7555.57796500
81418187

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C31H29N3O7/c1-34-13-11-20-23(29-30(41-16-40-29)28(37)25(20)31(34)38)15-33-24(35)14-22(17-5-8-19(39-2)9-6-17)21-10-7-18-4-3-12-32-26(18)27(21)36/h3-10,12,22,36-37H,11,13-16H2,1-2H3,(H,33,35)
C31H29N3O7555.57796500
7938618

Double-bond stereo
InChI=1/C31H29N3O7/c1-19-9-11-21(12-10-19)31(37)41-25-14-13-20-7-5-6-8-23(20)24(25)17-33-34-28(35)18-32-30(36)22-15-26(38-2)29(40-4)27(16-22)39-3/h5-17H,18H2,1-4H3,(H,32,36)(H,34,35)/b33-17+
C31H29N3O7555.57795400
7941292

Double-bond stereo
InChI=1/C31H29N3O7/c1-4-40-23-13-9-21(10-14-23)31(37)41-26-15-11-20-7-5-6-8-24(20)25(26)18-33-34-29(35)19-32-30(36)22-12-16-27(38-2)28(17-22)39-3/h5-18H,4,19H2,1-3H3,(H,32,36)(H,34,35)/b33-18+
C31H29N3O7555.57795400
71269928

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C31H29N3O7/c1-18-24-4-2-3-5-26(24)41-27(18)15-34-14-25-28(16-34)40-22-8-6-19(7-9-22)13-32-29(35)17-39-23-11-20(30(36)33-25)10-21(12-23)31(37)38/h2-12,25,28H,13-17H2,1H3,(H,32,35)(H,33,36)(H,37,38)/t25-,28-/m0/s1
C31H29N3O7555.57795500
12345

Advertisement